SpaceOAR Vue
Why should you
watch the recorded webinars?
The enhanced visibility on a CT scan is designed to help physicians improve contouring accuracy of the prostate and rectum, potentially leading to more accurate treatment plan creations when compared to SpaceOAR™ Hydrogel. This may reduce the overall treatment costs per patient, time required to fuse CT and MRI images, and the hospital staff’s time spent in obtaining MRI reimbursement authorisation. 

Potential Operational Benefits

With the improved visibility of SpaceOAR Vue Hydrogel on a CT scan, a
department’s clinical workflow may be improved as the patient will not
need a post-procedural MRI for treatment planning. 


SpaceOAR Vue


Potential Clinical Benefits
For CT planning, physician-delineated prostate volume can be on average 15% smaller (under contouring) or 30% larger (over contouring) than the “true” prostate volume. With SpaceOAR Vue Hydrogel, you may be able to contour the prostate and rectum without the need for an additional MRI. This may also reduce any contouring inaccuracies, potentially leading to more accurate treatment plan creations. Accurate and consistent positioning of the patient from one fraction to the next is important to physicians, to ensure that treatment is delivered according to plan. CT radiopacity may provide an effective imaging option to MRI for patients with implanted metallic devices so you can care for a broader population of prostate cancer patients.
SpaceOAR Vue
SpaceOAR Vue Hydrogel Recorded Webinars
Meet the Expert Sessions
• Advancing Radiation Therapy
• Advancing Prostate Health
spaceOAR vue
Dr. Sean Collins
Radiation Oncologist   

Dr. Elisha Fredman
Radiation Oncologist

Dr. Preston Sprenkle

Prof. Heather Payne
Clinical Oncologist
Seeing is believing
Sign up to watch recorded webinars and to get a clear view of all benefits and possibilities that 
SpaceOAR Vue Hydrogel may offer to you and your patients. Simply fill out the registration form below. 
Internet Explorer is not supported by the platform.
If the registration page is not loading, please connect via Google Chrome or Microsoft Edge.
SpaceOAR Vue Hydrogel 3D Model
Patient stories
Patients treated with SpaceOAR Hydrogel report a higher quality of life after prostate cancer radiation 
treatment and experience minimal adverse side effects.1
Discover more stories


1. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.


Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.